EULAV Asset Management’s CVS Health CVS Stock Holding History

EULAV Asset Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-10,000	Closed	-$789K	–	296
2016 Q4	$789K	Sell	10,000 -105,561	-91%	-$8.54M	0.04%	250
2016 Q3	$10.3M	Buy	115,561 +70,561	+157%	+$6.66M	0.54%	68
2016 Q2	$4.31M	Sell	45,000 -11,000	-20%	-$1.1M	0.24%	142
2016 Q1	$5.81M	Sell	56,000 -61,000	-52%	-$5.93M	0.32%	116
2015 Q4	$11.4M	Sell	117,000 -11,000	-9%	-$1.08M	0.63%	54
2015 Q3	$12.3M	Buy	128,000 +11,600	+10%	+$1.22M	0.7%	41
2015 Q2	$12.2M	Buy	116,400 +58,000	+99%	+$5.93M	0.64%	51
2015 Q1	$6.03M	Hold	58,400	–	–	0.31%	118
2014 Q4	$5.63M	Hold	58,400	–	–	0.3%	124
2014 Q3	$4.65M	Sell	58,400 -45,000	-44%	-$3.55M	0.25%	146
2014 Q2	$7.79M	Buy	103,400 +14,000	+16%	+$1.06M	0.42%	89
2014 Q1	$6.69M	Buy	89,400 +19,000	+27%	+$1.34M	0.36%	97
2013 Q4	$5.04M	Buy	70,400 +18,000	+34%	+$1.16M	0.27%	126
2013 Q3	$2.97M	Buy	52,400 +10,400	+25%	+$620K	0.17%	190
2013 Q2	$2.4M	Buy	+42,000	New	+$2.43M	0.15%	220

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

EULAV Asset Management's CVS Position: Q1 2017 in Review

EULAV Asset Management sold out of CVS Health (CVS) in Q1 2017, closing a stake of 10,000 shares — an estimated $789K sold.

EULAV Asset Management first reported a position in CVS in Q2 2013 and held it in 15 quarters. The position peaked at $12.3M in Q3 2015. 1,575 funds tracked by Wall St. Rank hold CVS as of Q1 2017.

EULAV Asset Management reported no remaining CVS Health position as of Q1 2017 after selling out during the quarter.
EULAV Asset Management sold 10,000 CVS Health shares in Q1 2017, an estimated $789K.
EULAV Asset Management first reported a position in CVS Health in Q2 2013 and held it in 15 quarters.
EULAV Asset Management's CVS Health position peaked at $12.3M in Q3 2015.
1,575 funds tracked by Wall St. Rank held CVS Health as of Q1 2017.

Based on EULAV Asset Management's 13F filing for Q1 2017, filed 12 May 2017.